ROCKWELL AUTOMATION, INC (ROK)
As-reported financials and SEC filings for ROCKWELL AUTOMATION, INC. The latest annual period is FY2025. The latest reported quarter is Q3 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About ROCKWELL AUTOMATION, INC
Rockwell Automation, Inc. provides industrial automation and digital transformation solutions globally. Its products and services include intelligent devices such as drives and sensors, software and control systems, and lifecycle services like digital consulting and cybersecurity. The company serves various industries including automotive, semiconductor, food and beverage, energy, and chemicals.
Snapshot
Fundamentals are from SEC filings for FY2025, the latest annual period (ended September 30, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Rockwell Automation
- Revenue grew 0.9% to $8.3B in FY2025, after a 8.8% decline the year before.
- Most recent quarter Q3 FY2026: revenue $2.3B, up 7.9% from Q3 FY2025.
- Free cash flow was $1.4B in FY2025, 16.3% of revenue.
- Net income fell 8.8% to $869M in FY2025.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Rockwell Automation’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Rockwell Automation’s return on equity of 23.4% ranks in the 89th percentile of the 473 Healthcare companies reporting it. Rockwell Automation’s operating margin of 20.4% ranks in the 88th percentile of the 399 Healthcare companies reporting it.
No reported insider purchases (code P) in the last 90 days; 4 insider sales totaling $1.0M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Institutional ownership
Held by 3 of the superinvestors we track (plus 4 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).
| Investor | As of | Position value | Shares | Change |
|---|---|---|---|---|
| Markel Group | Q2 2026 | $76.7M | 154.9K | Held |
| D. E. Shawquant | Q2 2026 | $72.2M | 145.7K | Reduced |
| AQR Capital Managementquant | Q2 2026 | $61.5M | 126.4K | Added |
| Gotham Asset Management | Q2 2026 | $50.5M | 102.0K | Added |
| Citadel Advisorsquant | Q2 2026 | $23.8M | 48.0K | Reduced |
| Bridgewater Associates | Q2 2026 | $9.3M | 18.7K | Reduced |
| Two Sigma Investmentsquant | Q2 2026 | $6.1M | 12.4K | Reduced |
No longer held by: Millennium Management (as of Q2 2026)
From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.
Recent insider activity
Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.
| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
2026-08-27 filed 2026-08-28 | Watson Patricia ADirector | Sell | 1.1K | $431.43 | $475K |
2026-08-20 filed 2026-08-21 | Rothe Christian ESr. VP and CFO | Sell | 590 | $434.30 | $256K |
2026-07-16 filed 2026-07-17 | Riesterer Terry L.Vice President and Controller | Sell | 281 | $453.24 | $127K |
2026-06-04 | Fordenwalt Matthew W.SVP Lifecycle Services | Sell | 377 | $460.51 | $174K |
2026-06-02 filed 2026-06-03 | Fordenwalt Matthew W.SVP Lifecycle Services | Sell | 218 | $456.34 | $99K |
2026-05-20 filed 2026-05-21 | MILLER JOHN MVP and Chief IP Counsel | Sell | 700 | $426.02 | $298K |
2026-05-20 filed 2026-05-21 | MILLER JOHN MVP and Chief IP Counsel | Sell | 354 | $426.02 | $151K |
2026-05-07 filed 2026-05-08 | Riesterer Terry L.Vice President and Controller | Sell | 2.9K | $452.02 | $1.3M |
2026-05-07 filed 2026-05-08 | Riesterer Terry L.Vice President and Controller | Sell | 1.1K | $451.83 | $497K |
2026-05-05 filed 2026-05-06 | Nardecchia ChristopherSVP, Chief Information Officer | Sell | 1.4K | $447.37 | $627K |
2026-05-05 filed 2026-05-06 | Nardecchia ChristopherSVP, Chief Information Officer | Sell | 586 | $440.82 | $258K |
2026-05-05 filed 2026-05-06 | Nardecchia ChristopherSVP, Chief Information Officer | Sell | 550 | $450.04 | $248K |
Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-08-14 | 3.6M | -6.2% | 3.37 |
| 2026-07-31 | 3.8M | +1.7% | 5.31 |
| 2026-07-15 | 3.8M | -10.6% | 5.37 |
| 2026-06-30 | 4.2M | +21.4% | 3.68 |
| 2026-06-15 | 3.5M | +5.6% | 5.71 |
| 2026-05-29 | 3.3M | +0.5% | 4.58 |
| 2026-05-15 | 3.3M | +0.0% | 3.41 |
| 2026-04-30 | 3.3M | -0.0% | 5.19 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $8.34B | $8.26B | $9.06B | $7.76B | $7.00B |
| Gross profit | $4.02B | $3.85B | $4.42B | $3.10B | $2.90B |
| Operating income | $1.70B | $1.59B | $1.93B | — | — |
| Net income | $869.0M | $953.0M | $1.39B | $932.2M | $1.36B |
| Diluted EPS | $7.67 | $8.28 | $11.95 | $7.97 | $11.58 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash and equivalents | $468.0M | $471.0M | $1.07B | $490.7M | $662.2M |
| Current assets | $3.91B | $3.88B | $4.91B | $3.61B | $3.06B |
| Total assets | $11.22B | $11.23B | $11.30B | $10.76B | $10.70B |
| Current liabilities | $3.44B | $3.60B | $3.37B | $3.57B | $2.99B |
| Long-term debt | $2.61B | $2.56B | $2.86B | $2.87B | $3.46B |
| Total liabilities | $7.51B | $7.56B | $7.56B | $7.74B | $8.01B |
| Total equity | $3.71B | $3.67B | $3.74B | $3.02B | $2.69B |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating cash flow | $1.54B | $864.0M | $1.37B | $823.1M | $1.26B |
| Capital expenditure | $186.0M | $225.0M | $161.0M | $141.1M | $120.3M |
| Free cash flow | $1.36B | $639.0M | $1.21B | $682.0M | $1.14B |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | $2.31B | 7.9% | $408.0M | $3.65 |
| Q2 FY2026 | $2.24B | 11.9% | $350.0M | $3.10 |
| Q1 FY2026 | $2.10B | 11.9% | $305.0M | $2.69 |
| Q4 FY2025 | $2.32B | 13.8% | $138.0M | $1.22 |
| Q3 FY2025 | $2.14B | 4.5% | $295.0M | $2.60 |
| Q2 FY2025 | $2.00B | -5.9% | $252.0M | $2.22 |
| Q1 FY2025 | $1.88B | -8.3% | $184.0M | $1.61 |
| Q4 FY2024 | $2.04B | -20.6% | $240.0M | $2.11 |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Selected SEC filings
Largest Healthcare peers
Monitor ROK
Get an alert when Rockwell Automation files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor ROK freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.